Akynzeo® (fosnetupitant/palonosetron) – New formulation
April 20, 2018 - Helsinn announced the FDA approval of Akynzeo (fosnetupitant/palonosetron) injection, in combination with dexamethasone in adults for the prevention of acute and delayed nausea and vomiting (N/V) associated with initial and repeat courses of highly emetogenic cancer chemotherapy.
Top